TYMP and metastatic colorectal cancer: Trifluridine was recently approved for use in metastatic colorectal cancer by the U.S. Food and Drug Administration (FDA) as part of Lonsurf, which also includes Tiperacil, a thymidine phosphorylase (TP) inhibitor [40].